methamphetamine and Psychotic Disorders

methamphetamine has been researched along with Psychotic Disorders in 93 studies

Research

Studies (93)

Timeframe	Studies, this research(%)	All Research%
pre-1990	15 (16.13)	18.7374
1990's	0 (0.00)	18.2507
2000's	13 (13.98)	29.6817
2010's	40 (43.01)	24.3611
2020's	25 (26.88)	2.80

Authors

Authors	Studies
Kalayasiri, R; Krusong, K; Maes, M; Rungnirundorn, T	1
Asmal, L; du Plessis, S; Emsley, R; Hendrikse, CB; Luckhoff, HK; Olivier, MR; Phahladira, L; Scheffler, F; Smit, AM	1
Balkchyan, AA; Duval, CJ; Keshishian, T; Murray, SB; Nagata, JM; Pedersen, ER; Sarkisyan, A	1
Chen, T; Guan, F; Ma, D; Ni, T; Wang, H; Wang, S; Xue, Y; Zhu, L; Zhu, W; Zhu, Y	1
Babina, A; Sokolova, I; Vysotskyi, M	1
Cotton, SM; Koopowitz, SM; Stein, DJ; Thomas, KGF; Uhlmann, A	1
Al-Hakeim, HK; Almulla, AF; Altufaili, MF; Maes, M; Moustafa, SR	1
Deng, H; Guan, F; Jia, X; Jiang, W; Kong, Z; Lai, W; Li, P; Wang, J; Yang, M; Ye, C; Zhao, M	1
Chen, T; Guan, FL; Han, W; Zhang, JB; Zhao, LR; Zhu, L	1
Clingan, SE; Fei, Z; Marder, SR; Mooney, LJ; Zhu, Y; Zito, MF	1
El-Mallakh, RS; Goetz, BL; McQuaide, S; Ruch, TQ; Terrell, CL; Yeske, E	1
Arunogiri, S; Berk, M; Castle, D; Clare, PJ; Kelly, PJ; Lubman, DI; Manning, V; McKetin, R; Turner, A	1
Al-Hakeim, HK; Alhaideri, AF; Almulla, AF; Altufaili, MF; Maes, M; Moustafa, SR	1
Ahmadkhaniha, HR; Alavi, K; Arya, S; Ebrahimi, A; Kamyab, A; Kamyab, P; Pourmehdiardebili, M; Sanatkar, SA; Zarei, Z	1
Bach, PJ; Elefante, RJO; Nolan, S	1
Liu, T; London, ED; Yang, C; Yang, M	1
Indrakamhaeng, D; Junkuy, A; Khuwuthyakorn, P; Lamyai, W; Pono, K; Saengsin, A; Songhong, N; Sribanditmongkol, P; Srisurapanont, M	1
Chen, M; Cheng, L; Greening, DW; Hill, AF; Notaras, M; Simpson, RJ; Smith, JD; van den Buuse, M; Xu, R	1
Chen, T; Du, J; Jiang, H; Su, H; Sun, Q; Yu, S; Zhang, K; Zhao, M; Zhao, Y; Zhong, N	1
Chan, G; Dawe, S; Hides, L; Kavanagh, DJ; McKetin, R; Saunders, JB; Teesson, M; Young, RM	1
Freckelton, I	1
Indrakamhaeng, D; Jantamo, P; Khuwuthyakorn, P; Lamyai, W; Pono, K; Saengsin, A; Songhong, N; Srisurapanont, M	1
Barr, AM; Buchanan, T; Gicas, KM; Honer, WG; Jones, AA; Lang, DJ; Leonova, O; Lima, VD; MacEwan, GW; Montaner, JSG; Panenka, WJ; Procyshyn, RM; Rauscher, A; Schmitt, TA; Seyedin, S; Smith, GN; Thornton, AE; Vertinsky, AT; Vila-Rodriguez, F; Willi, TS	1
Chen, JC; Liao, IM	1
Likhitsathian, S; Maneeton, B; Maneeton, N; Oon-Arom, A; Srisurapanont, M; Suradom, C; Suttajit, S	1
Boden, JM; Foulds, JA; McKetin, R; Newton-Howes, G	1
Dong, H; Hao, W; Shen, Y	1
Ipser, JC; Stein, DJ; Uhlmann, A; Wilson, D	1
Iamjan, SA; Nudmamud-Thanoi, S; Reynolds, GP; Thanoi, S; Watiktinkorn, P	1
Dawe, S; Hides, L; Kavanagh, DJ; McKetin, R; Saunders, JB	1
Cai, WX; Hu, Q; Li, C; Liu, C; Tang, T; Zang, YY; Zhang, S	1
Duong Thi, H; Feelemyer, J; Hoang Thi, G; Jarlais, DCD; Khuat Thi Hai, O; Laureillard, D; Le, SM; Michel, L; Moles, JP; Nagot, N; Nham Thi, TT; Peries, M; Pham Minh, K; Pham Thu, X; Quillet, C; Rapoud, D; Study Team, D; Vallo, R; Vu Hai, V	1
Detherage, JP; Greene, PJ; Mann, DM; Marco, CA; Ross, DE	1
Aoki, Y; Ishii, T; Itokawa, M; Kasai, K; Kurachi, M; Mozue, Y; Okazaki, Y; Orikabe, L; Sudo, Y; Suzuki, M; Takayanagi, Y; Yahata, N; Yamasue, H	1
Bernacer, J; Clark, L; Corlett, PR; Fletcher, PC; McFarlane, B; Murray, GK; Ramachandra, P; Robbins, TW; Turner, DC	1
Fukunari, A; Kajii, Y; Kano, S; Kondo, MA; Miwa, K; Ohzeki, H; Okada, K; Sakaue, M; Sawa, A; Takemoto, K; Tamura, M; Tezuka, T; Yasumatsu, H	1
Barr, AM; Bouchard, V; Brink, J; Buchanan, T; Goldner, E; Honer, WG; Kang, S; Lang, D; Lecomte, T; MacEwan, W; Mueser, KT; Thornton, AE	1
Howells, FM; Meintjes, E; Sinclair, H; Stein, DJ; Temmingh, H; Uhlmann, A; Wilson, D	1
Cornish, JL; Franklin, JL; Goodchild, AK; Haynes, PA; Mirzaei, M; Wearne, TA	1
Chen, CK; Chen, TT; Chen, YC; Huang, MC; Lin, SK; Ree, SC; Wang, LJ	1
Dawe, S; Hides, L; Kavanagh, DJ; McKetin, R; Saunders, JB; Teesson, M; Young, RM	1
Hashimoto, K; Iyo, M; Kanahara, N; Oda, Y; Shirayama, Y; Tadokoro, S; Takase, M; Watanabe, H	1
Iida, J; Kimoto, S; Kishimoto, N; Kishimoto, T; Makinodan, M; Matsuda, Y; Matsuoka, K; Morimoto, T; Nishihata, Y; Ota, T; Takahashi, M; Takata, T; Takebayashi, Y; Tanimura, Y; Toritsuka, M; Yamamuro, K; Yoshino, H	1
Kirby, T	1
Gedzior, JS; Matthew, BJ	1
Fouche, JP; Koen, N; Meintjes, EM; Stein, DJ; Uhlmann, A; Wilson, D	1
White, CM	1
Iida, J; Kimoto, S; Kishimoto, N; Kishimoto, T; Makinodan, M; Nakanishi, Y; Ota, T; Tanaka, S; Yamamuro, K	1
Ali, R; Baker, AL; Dawe, S; Gardner, J; Leach, LS; Lubman, DI; McKetin, R; Voce, A	1
Barrio, P; Fàbregas, JM; Gaskell, M; Goti, J; Vilardell, S	1
Cornish, JL; Franklin, JL; Goodchild, AK; Parker, LM; Wearne, TA	1
Harvey, R; Kekulawala, S; Kent, M; Mostafa, S; Tucker, MG	1
Abdolmaleky, HM; Barati, M; Ghadirivasfi, M; Ghasemzadeh, MR; Joghataei, M; Mehrabi, S; Mousavi-Behbahani, Z; Narimani, S; Nohesara, S; Soleimani, M; Taban, M; Thiagalingam, S	1
Harvey, BH; Ipser, JC; Stein, DJ; Taylor, P; Uhlmann, A; Wilson, D	1
Howells, FM; Shelly, J; Sibeko, G; Sinclair, H; Stein, DJ; Temmingh, H; Uhlmann, A; Wilson, D	1
Amini, H; Hajebi, A; Kashani, L; Sharifi, V	1
Baker, AL; Dawe, S; Lubman, DI; McKetin, R; Voce, A	1
Harano, M; Hashimoto, K; Inada, T; Iwata, N; Iyo, M; Kanahara, N; Komiyama, T; Miyatake, R; Ozaki, N; Sekine, Y; Sora, I; Ujike, H; Yamada, M	1
Tucker, P	1
Inada, T; Iwata, N; Iyo, M; Kodama, M; Kotaka, T; Kuroda, S; Nakata, K; Okahisa, Y; Ozaki, N; Sora, I; Takaki, M; Uchimura, N; Ujike, H; Yamada, M	1
Devlin, K; Hickey, K; Lawrence, K; McKetin, R	1
Booncharoen, H; Chutha, W; Dumrongchai, U; Kittirattanapaiboon, P; Mahatnirunkul, S; Thummawomg, P	1
Hellemann, G; London, ED; Miotto, K; Nestor, L; Rawson, R; Scanlon, G; Sugar, C; Zorick, T	1
Inoue, H; Ishii, T; Itokawa, M; Kasai, K; Kurachi, M; Mozue, Y; Okazaki, Y; Orikabe, L; Sudo, Y; Suzuki, M; Takayanagi, Y; Yamasue, H	1
Alda, M; Beranek, M; Hosák, L; Serý, O	1
Cheer, JF; Glick, SD; Morra, JT	1
Kobayashi, K; Mishina, M; Miyazaki, M; Mouri, A; Nabeshima, T; Noda, Y; Yamada, K	1
Ali, RL; Baker, AL; Dawe, S; Lubman, DI; McKetin, R	1
Ashby, CR; Isoda, H; Iyo, M; Kawai, M; Minabe, Y; Mori, N; Sakahara, H; Sekine, Y; Suzuki, K; Takei, N	1
CARR, RB	1
ALANO, J; BARRE, N; BRETON, Y; CAHN, J; DUBRASQUET, M; HEROLD, M	2
DE CAROLIS, V; GIBERTI, F; ROSSI, R	2
JOHNSEN, G	1
PROUT, CT	1
SCHWARTZ, M; SHAGASS, C	1
Ando, N; Morimoto, K; Ninomiya, T; Suwaki, H; Watanabe, T	1
Ball, DM; Chen, CK; Hu, X; Li, T; Lin, SK; Loh, el-W; Murray, RM; Sham, PC	1
Ball, D; Chen, CK; Lin, SK; Loh, el-W; Murray, RM; Sham, PC	1
Harano, M; Inada, T; Iwata, N; Iwata, Y; Iyo, M; Kawai, M; Komiyama, T; Matsuzaki, H; Minabe, Y; Mori, N; Nakamura, K; Ozaki, N; Sekine, Y; Sora, I; Suzuki, A; Suzuki, K; Takebayashi, K; Takei, N; Ujike, H; Yamada, M	1
Brummelte, S; Neddens, J; Teuchert-Noodt, G	1
Ang, A; Glasner-Edwards, S; Hillhouse, M; Marinelli-Casey, P; Mooney, LJ; Rawson, R	1
Checkley, SA	1
Dobies, DF; Ellison, JM	1
Dawirs, RR; Teuchert-Noodt, G	1
Goto, K; Ikemoto, S; Ishiguro, T; Nishijima, K; Yoshino, T; Yui, K	1
Goto, K; Ikemoto, S; Yui, K	1
Sudilovsky, A	1
Andrews, G; Kiloh, LG; Neilson, M	1
Jovanović, UJ	1
Perez-Reyes, M	1
Ban, TA; Kral, VA; Lehmann, HE; Silver, D	1

Reviews

4 review(s) available for methamphetamine and Psychotic Disorders

Article	Year
Efficacy and dropout rates of antipsychotic medications for methamphetamine psychosis: A systematic review and network meta-analysis. Drug and alcohol dependence, 2021, 02-01, Volume: 219 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Haloperidol; Humans; Methamphetamine; Network Meta-Analysis; Olanzapine; Patient Dropouts; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia	2021
Mephedrone and 3,4-Methylenedioxypyrovalerone (MDPV): Synthetic Cathinones With Serious Health Implications. Journal of clinical pharmacology, 2016, Volume: 56, Issue:11 Topics: Animals; Benzodioxoles; Humans; Illicit Drugs; Methamphetamine; Psychotic Disorders; Psychotropic Drugs; Pyrrolidines; Substance-Related Disorders; Synthetic Cathinone	2016
Substance misuse and early psychosis. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2009, Volume: 17, Issue:4 Topics: Adolescent; Adult; Age of Onset; Alcohol Drinking; Amphetamine-Related Disorders; Cognition Disorders; Humans; Marijuana Abuse; Methamphetamine; Psychoses, Substance-Induced; Psychotic Disorders; Substance-Related Disorders; Young Adult	2009
A novel pharmacological concept in an animal model of psychosis. Acta psychiatrica Scandinavica. Supplementum, 2001, Issue:408 Topics: Adrenergic Uptake Inhibitors; Animals; Dentate Gyrus; Disease Models, Animal; Dopamine; Gerbillinae; Hippocampus; Immunohistochemistry; Inhibition, Psychological; Methamphetamine; Nerve Net; Prefrontal Cortex; Psychotic Disorders; Reaction Time	2001

Trials

3 trial(s) available for methamphetamine and Psychotic Disorders

Article	Year
How does a family history of psychosis influence the risk of methamphetamine-related psychotic symptoms: Evidence from longitudinal panel data. Addiction (Abingdon, England), 2023, Volume: 118, Issue:10 Topics: Amphetamine-Related Disorders; Hallucinations; Humans; Methamphetamine; Psychoses, Substance-Induced; Psychotic Disorders; Risk Factors	2023
Spontaneous recurrence of methamphetamine-induced paranoid-hallucinatory states in female subjects: susceptibility to psychotic states and implications for relapse of schizophrenia. Pharmacopsychiatry, 2002, Volume: 35, Issue:2 Topics: Adult; Amphetamine-Related Disorders; Biogenic Monoamines; Central Nervous System Stimulants; Female; Hallucinations; Humans; Methamphetamine; Paranoid Disorders; Psychotic Disorders; Recurrence; Schizophrenic Psychology	2002
Differences in sedative susceptibility between types of depression. Clinical and neurophysiological significance. Archives of general psychiatry, 1968, Volume: 19, Issue:1 Topics: Adult; Age Factors; Anxiety Disorders; Arousal; Bipolar Disorder; Central Nervous System; Depression; Depressive Disorder, Major; Female; Galvanic Skin Response; Humans; Injections, Intravenous; Insulin; Male; Methamphetamine; Middle Aged; Placebos; Psychotic Disorders; Sex Factors; Sleep; Sodium; Thiopental	1968

Other Studies

86 other study(ies) available for methamphetamine and Psychotic Disorders

Article	Year
Leukocyte telomere length is not shortened in methamphetamine dependence or methamphetamine-induced psychosis but is increased following traumatic events. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2022, Volume: 23, Issue:8 Topics: Alcoholism; Amphetamine-Related Disorders; Humans; Leukocytes; Methamphetamine; Psychotic Disorders; Substance Withdrawal Syndrome; Telomere; Tobacco Use Disorder	2022
The associations of cannabis and methamphetamine use with cognitive performance over the first 2 years of treatment in schizophrenia spectrum disorders. Early intervention in psychiatry, 2022, Volume: 16, Issue:11 Topics: Cannabis; Cognition; Humans; Longitudinal Studies; Methamphetamine; Neuropsychological Tests; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology	2022
Methamphetamine use and disordered eating: a case study of an understudied phenomenon. Eating and weight disorders : EWD, 2022, Volume: 27, Issue:7 Topics: Body Image; Feeding and Eating Disorders; Female; Humans; Methamphetamine; Psychotic Disorders	2022
Medial prefrontal cortex Notch1 signalling mediates methamphetamine-induced psychosis via Hes1-dependent suppression of GABA Molecular psychiatry, 2022, Volume: 27, Issue:10 Topics: Animals; Central Nervous System Stimulants; Methamphetamine; Mice; Motor Activity; Prefrontal Cortex; Psychotic Disorders; Receptors, GABA-B; Receptors, Notch; Transcription Factor HES-1	2022
Characteristics of Amphetamine Psychosis with Respect to the Length of Drug Exposure. CNS & neurological disorders drug targets, 2023, Volume: 22, Issue:4 Topics: Amphetamine; Humans; Methamphetamine; Psychoses, Substance-Induced; Psychotic Disorders; Substance-Related Disorders	2023
Executive function in methamphetamine users with and without psychosis. Psychiatry research, 2022, Volume: 317 Topics: Amphetamine-Related Disorders; Executive Function; Humans; Methamphetamine; Neuropsychological Tests; Psychotic Disorders	2022
Increased Lipid Peroxidation and Lowered Antioxidant Defenses Predict Methamphetamine Induced Psychosis. Cells, 2022, 11-21, Volume: 11, Issue:22 Topics: Antioxidants; Humans; Lipid Peroxidation; Male; Methamphetamine; Psychotic Disorders; Zinc	2022
Common gray matter loss in the frontal cortex in patients with methamphetamine-associated psychosis and schizophrenia. NeuroImage. Clinical, 2022, Volume: 36 Topics: Brain; Frontal Lobe; Gray Matter; Humans; Magnetic Resonance Imaging; Methamphetamine; Psychotic Disorders; Schizophrenia	2022
Application Prospect of Integrative Omics in Forensic Identification of Methamphetamine-Associated Psychosis. Fa yi xue za zhi, 2022, Oct-25, Volume: 38, Issue:5 Topics: Diagnosis, Differential; Humans; Methamphetamine; Psychoses, Substance-Induced; Psychotic Disorders; Schizophrenia	2022
Psychosis among individuals with methamphetamine use disorder is associated with elevated rates of hospitalizations and emergency department visits across an academic health care system. Journal of substance use and addiction treatment, 2023, Volume: 151 Topics: Delivery of Health Care; Emergency Service, Hospital; Hospitalization; Humans; Methamphetamine; Psychotic Disorders; United States	2023
Prolonged psychosis with reformulated methamphetamine. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2023, Volume: 35, Issue:2 Topics: Humans; Methamphetamine; Psychotic Disorders	2023
Increased AGE-RAGE axis stress in methamphetamine abuse and methamphetamine-induced psychosis: Associations with oxidative stress and increased atherogenicity. Addiction biology, 2023, Volume: 28, Issue:10 Topics: Amphetamine-Related Disorders; Antioxidants; Case-Control Studies; Copper; Humans; Magnesium; Methamphetamine; Oxidative Stress; Psychotic Disorders	2023
Evaluating the association of vitamin D3, parathyroid hormone, and C-reactive protein serum levels in patients with an acute psychotic episode: a cross-sectional study in tertiary centre in Iran. BMC psychiatry, 2023, 10-06, Volume: 23, Issue:1 Topics: C-Reactive Protein; Calcium; Cholecalciferol; Chronic Disease; Cross-Sectional Studies; Humans; Iran; Methamphetamine; Parathyroid Hormone; Phosphorus; Psychotic Disorders; Vitamin D	2023
Vigilance needed with methamphetamine-associated psychosis. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2023, 10-10, Volume: 195, Issue:39 Topics: Central Nervous System Stimulants; Humans; Methamphetamine; Psychoses, Substance-Induced; Psychotic Disorders	2023
Methamphetamine-associated psychosis: links to drug use characteristics and similarity to primary psychosis. International journal of psychiatry in clinical practice, 2020, Volume: 24, Issue:1 Topics: Adult; Age of Onset; Amphetamine-Related Disorders; Brief Psychiatric Rating Scale; Central Nervous System Stimulants; Female; Humans; Male; Methamphetamine; Middle Aged; Paranoid Disorders; Psychoses, Substance-Induced; Psychotic Disorders; Schizophrenia; Severity of Illness Index; Time Factors	2020
Risks of psychosis in methamphetamine users: cross-sectional study in Thailand. BMJ open, 2019, 10-14, Volume: 9, Issue:10 Topics: Adolescent; Adult; Age Distribution; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cross-Sectional Studies; Female; Hospitals, Psychiatric; Humans; Logistic Models; Male; Methamphetamine; Middle Aged; Neuropsychological Tests; Prevalence; Psychotic Disorders; Retrospective Studies; Risk Assessment; Sex Distribution; Thailand	2019
Chronic methamphetamine interacts with BDNF Val66Met to remodel psychosis pathways in the mesocorticolimbic proteome. Molecular psychiatry, 2021, Volume: 26, Issue:8 Topics: Amphetamine-Related Disorders; Animals; Brain-Derived Neurotrophic Factor; Genotype; Methamphetamine; Mice; Polymorphism, Single Nucleotide; Proteome; Psychotic Disorders	2021
An association study between methamphetamine use disorder with psychosis and polymorphisms in MiRNA. Neuroscience letters, 2020, 01-19, Volume: 717 Topics: Adult; Amphetamine-Related Disorders; Case-Control Studies; Female; Genotype; Humans; Linkage Disequilibrium; Male; Methamphetamine; MicroRNAs; Polymorphism, Single Nucleotide; Psychotic Disorders	2020
Direction of the relationship between methamphetamine use and positive psychotic symptoms in regular methamphetamine users: evidence from a prospective cohort study. The British journal of psychiatry : the journal of mental science, 2021, Volume: 219, Issue:1 Topics: Adult; Amphetamine-Related Disorders; Australia; Female; Humans; Methamphetamine; Prospective Studies; Psychoses, Substance-Induced; Psychotic Disorders	2021
Methamphetamine-induced Psychosis and Mental Impairment: A Challenge from New Zealand. Journal of law and medicine, 2019, Volume: 27, Issue:2 Topics: Amphetamine-Related Disorders; Criminal Law; Humans; Insanity Defense; Methamphetamine; New Zealand; Psychotic Disorders	2019
Cognitive impairment in methamphetamine users with recent psychosis: A cross-sectional study in Thailand. Drug and alcohol dependence, 2020, 05-01, Volume: 210 Topics: Adult; Amphetamine-Related Disorders; Cognitive Dysfunction; Cross-Sectional Studies; Female; Humans; Male; Methamphetamine; Middle Aged; Neuropsychological Tests; Psychiatric Status Rating Scales; Psychotic Disorders; Surveys and Questionnaires; Thailand	2020
Associations of substance use, psychosis, and mortality among people living in precarious housing or homelessness: A longitudinal, community-based study in Vancouver, Canada. PLoS medicine, 2020, Volume: 17, Issue:7 Topics: Adult; Alcoholism; British Columbia; Female; Housing; Humans; Ill-Housed Persons; Kaplan-Meier Estimate; Male; Methamphetamine; Middle Aged; Psychotic Disorders; Residence Characteristics; Risk Factors; Substance-Related Disorders; Time Factors	2020
Lack of dopamine D4 receptor participation in mouse hyperdopaminergic locomotor response. Behavioural brain research, 2021, 01-01, Volume: 396 Topics: Amphetamine-Related Disorders; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System Sensitization; Clozapine; Disease Models, Animal; Dopamine Agents; Locomotion; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Transgenic; Psychotic Disorders; Pyridines; Pyrroles; Receptors, Dopamine D4	2021
Methamphetamine use and psychotic symptoms: findings from a New Zealand longitudinal birth cohort. Psychological medicine, 2023, Volume: 53, Issue:3 Topics: Adult; Amphetamine-Related Disorders; Birth Cohort; Child; Humans; Infant, Newborn; Longitudinal Studies; Methamphetamine; New Zealand; Psychoses, Substance-Induced; Psychotic Disorders; Risk Factors	2023
Assessing the mediating role of impulsivity between methamphetamine-induced psychotic disorders and increased gambling severity in methamphetamine-dependent individuals. European archives of psychiatry and clinical neuroscience, 2022, Volume: 272, Issue:6 Topics: Adult; Amphetamine-Related Disorders; Gambling; Humans; Impulsive Behavior; Methamphetamine; Psychotic Disorders	2022
Social cognition and aggression in methamphetamine dependence with and without a history of psychosis. Metabolic brain disease, 2018, Volume: 33, Issue:2 Topics: Adolescent; Adult; Aggression; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cognition; Emotions; Female; Humans; Male; Methamphetamine; Psychotic Disorders; Social Behavior; Young Adult	2018
Genetic variation of GRIA3 gene is associated with vulnerability to methamphetamine dependence and its associated psychosis. Journal of psychopharmacology (Oxford, England), 2018, Volume: 32, Issue:3 Topics: Adult; Amphetamine-Related Disorders; Asian People; Brain-Derived Neurotrophic Factor; Case-Control Studies; Central Nervous System Stimulants; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Male; Methamphetamine; Middle Aged; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Psychotic Disorders; Receptors, AMPA; Schizophrenia; Young Adult	2018
First psychotic episode risk markers for primary psychosis amongst people who use methamphetamine. Schizophrenia research, 2018, Volume: 199 Topics: Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Delusions; Hallucinations; Humans; Methamphetamine; Psychoses, Substance-Induced; Psychotic Disorders; Risk; Young Adult	2018
Changes in Gray Matter Density, Regional Homogeneity, and Functional Connectivity in Methamphetamine-Associated Psychosis: A Resting-State Functional Magnetic Resonance Imaging (fMRI) Study. Medical science monitor : international medical journal of experimental and clinical research, 2018, Jun-13, Volume: 24 Topics: Adult; Brain; Brain Mapping; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Psychoses, Substance-Induced; Psychotic Disorders; Retrospective Studies; Schizophrenia; Young Adult	2018
Psychiatric Comorbidities among People Who Inject Drugs in Hai Phong, Vietnam: The Need for Screening and Innovative Interventions. BioMed research international, 2018, Volume: 2018 Topics: Adult; Alcohol Drinking; Amphetamine-Related Disorders; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Methamphetamine; Prevalence; Psychotic Disorders; Sex Factors; Vietnam	2018
Methamphetamine psychosis: Lack of association with stimulant prescription ADHD medications. The American journal of emergency medicine, 2019, Volume: 37, Issue:9 Topics: Adolescent; Adult; Aged; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Female; Humans; Illicit Drugs; Male; Methamphetamine; Middle Aged; Practice Patterns, Physicians'; Psychotic Disorders; Retrospective Studies; Young Adult	2019
Volume reductions in frontopolar and left perisylvian cortices in methamphetamine induced psychosis. Schizophrenia research, 2013, Volume: 147, Issue:2-3 Topics: Adult; Case-Control Studies; Central Nervous System Stimulants; Female; Frontal Lobe; Functional Laterality; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methamphetamine; Psychotic Disorders; Temporal Lobe; Young Adult	2013
Methamphetamine-induced disruption of frontostriatal reward learning signals: relation to psychotic symptoms. The American journal of psychiatry, 2013, Volume: 170, Issue:11 Topics: Adult; Amisulpride; Antipsychotic Agents; Basal Ganglia; Central Nervous System Stimulants; Corpus Striatum; Female; Functional Neuroimaging; Humans; Learning; Magnetic Resonance Imaging; Male; Methamphetamine; Nucleus Accumbens; Prefrontal Cortex; Psychotic Disorders; Reinforcement, Psychology; Reward; Sulpiride	2013
Cuprizone short-term exposure: astrocytic IL-6 activation and behavioral changes relevant to psychosis. Neurobiology of disease, 2013, Volume: 59 Topics: Animals; Astrocytes; Brain; Central Nervous System Stimulants; Chelating Agents; Copper; Cuprizone; Disease Models, Animal; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Hallucinogens; Hyperkinesis; Interleukin-6; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Phencyclidine; Psychotic Disorders; Time Factors	2013
Predictors of persistent psychotic symptoms in persons with methamphetamine abuse receiving psychiatric treatment. The Journal of nervous and mental disease, 2013, Volume: 201, Issue:12 Topics: Adult; Age Factors; Amphetamine-Related Disorders; Antisocial Personality Disorder; Depression; Female; Humans; Interview, Psychological; Longitudinal Studies; Male; Methamphetamine; Psychiatric Status Rating Scales; Psychotic Disorders; Time Factors	2013
(1)H-magnetic resonance spectroscopy ((1)H-MRS) in methamphetamine dependence and methamphetamine induced psychosis. Schizophrenia research, 2014, Volume: 153, Issue:1-3 Topics: Adolescent; Adult; Aspartic Acid; Brain; Choline; Creatine; Female; Glutamine; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Methamphetamine; Prefrontal Cortex; Protons; Psychotic Disorders; Substance-Related Disorders; Young Adult	2014
Methamphetamine-induced sensitization is associated with alterations to the proteome of the prefrontal cortex: implications for the maintenance of psychotic disorders. Journal of proteome research, 2015, Jan-02, Volume: 14, Issue:1 Topics: Animals; Central Nervous System Sensitization; Chromatography, Liquid; Databases, Protein; Electrophoresis, Polyacrylamide Gel; Male; Methamphetamine; Models, Neurological; Prefrontal Cortex; Proteome; Psychotic Disorders; Rats; Synapses; Tandem Mass Spectrometry	2015
Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users. Drug and alcohol dependence, 2015, Mar-01, Volume: 148 Topics: Adult; Amphetamine-Related Disorders; Cognition Disorders; Cross-Sectional Studies; Female; Humans; Longitudinal Studies; Male; Methamphetamine; Middle Aged; Neuropsychological Tests; Psychotic Disorders; Schizophrenia	2015
Primary and substance-induced psychotic disorders in methamphetamine users. Psychiatry research, 2015, Mar-30, Volume: 226, Issue:1 Topics: Adult; Age of Onset; Amphetamine-Related Disorders; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Methamphetamine; Psychoses, Substance-Induced; Psychotic Disorders; Symptom Assessment; Young Adult	2015
G protein-coupled receptor kinase 6/β-arrestin 2 system in a rat model of dopamine supersensitivity psychosis. Journal of psychopharmacology (Oxford, England), 2015, Volume: 29, Issue:12 Topics: Animals; Antipsychotic Agents; Arrestins; beta-Arrestin 2; beta-Arrestins; Dopamine; G-Protein-Coupled Receptor Kinases; Haloperidol; Male; Methamphetamine; Motor Activity; Psychotic Disorders; Rats; Rats, Wistar; Receptors, Dopamine D2; Up-Regulation	2015
Differential patterns of blood oxygenation in the prefrontal cortex between patients with methamphetamine-induced psychosis and schizophrenia. Scientific reports, 2015, Jul-16, Volume: 5 Topics: Adult; Female; Humans; Male; Methamphetamine; Middle Aged; Oxygen; Prefrontal Cortex; Psychotic Disorders; Schizophrenia; Speech	2015
Highlights from the 9th International Early Psychosis Conference, Tokyo, Japan. The lancet. Psychiatry, 2015, Volume: 2, Issue:1 Topics: Adolescent; Adult; Aged; Australia; Child; Denmark; Fatty Acids, Omega-3; Humans; Methamphetamine; Middle Aged; Psychopathology; Psychotic Disorders; Substance-Related Disorders; Tokyo; Young Adult	2015
Drug-induced parkinsonism following chronic methamphetamine use by a patient on haloperidol decanoate. International journal of psychiatry in medicine, 2015, Volume: 50, Issue:4 Topics: Adult; Amphetamine-Related Disorders; Diphenhydramine; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Humans; Injections, Intramuscular; Male; Methamphetamine; Neural Pathways; Nucleus Accumbens; Parkinson Disease, Secondary; Patient Admission; Patient Readmission; Psychotic Disorders; Receptors, Dopamine D2; Substance Abuse Treatment Centers; Substance Abuse, Intravenous; Substantia Nigra; Treatment Refusal	2015
Fronto-temporal alterations and affect regulation in methamphetamine dependence with and without a history of psychosis. Psychiatry research. Neuroimaging, 2016, Feb-28, Volume: 248 Topics: Adolescent; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cerebral Cortex; Diagnosis, Dual (Psychiatry); Emotions; Female; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Psychotic Disorders; Self-Control; Young Adult	2016
Reduced Prefrontal Cortex Hemodynamic Response in Adults with Methamphetamine Induced Psychosis: Relevance for Impulsivity. PloS one, 2016, Volume: 11, Issue:4 Topics: Adult; Case-Control Studies; Female; Hemodynamics; Humans; Impulsive Behavior; Male; Methamphetamine; Middle Aged; Prefrontal Cortex; Psychotic Disorders; Spectroscopy, Near-Infrared	2016
Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users. Psychiatry research, 2016, Apr-30, Volume: 238 Topics: Adult; Age Factors; Amphetamine-Related Disorders; Anxiety Disorders; Brief Psychiatric Rating Scale; Comorbidity; Conduct Disorder; Depressive Disorder, Major; Female; Hallucinations; Humans; Longitudinal Studies; Male; Methamphetamine; Prospective Studies; Psychoses, Substance-Induced; Psychotic Disorders; Risk Factors; Sex Factors	2016
Persistent psychotic symptoms after long-term heavy use of mephedrone: A two-case series. Adicciones, 2016, Jun-15, Volume: 28, Issue:3 Topics: Adult; Humans; Male; Methamphetamine; Psychotic Disorders; Substance-Related Disorders; Time Factors	2016
GABAergic mRNA expression is differentially expressed across the prelimbic and orbitofrontal cortices of rats sensitized to methamphetamine: Relevance to psychosis. Neuropharmacology, 2016, Volume: 111 Topics: Animals; GABA Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Male; Methamphetamine; Motor Activity; Prefrontal Cortex; Psychotic Disorders; Rats; Rats, Sprague-Dawley; Receptors, GABA; RNA, Messenger; Vesicular Inhibitory Amino Acid Transport Proteins	2016
Polysubstance-induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: a case report. Journal of medical case reports, 2016, Sep-06, Volume: 10, Issue:1 Topics: Adult; Amphetamine-Related Disorders; Antipsychotic Agents; Chlorpromazine; Clopenthixol; Droperidol; Drug Administration Schedule; Emergency Medical Services; Humans; Hypnotics and Sedatives; Lorazepam; Male; Marijuana Abuse; Methamphetamine; Psychotic Disorders; Time Factors; Treatment Outcome; Violence	2016
Methamphetamine-induced psychosis is associated with DNA hypomethylation and increased expression of AKT1 and key dopaminergic genes. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2016, Volume: 171, Issue:8 Topics: Adult; Amphetamine-Related Disorders; Case-Control Studies; Catechol O-Methyltransferase; DNA Methylation; Dopamine; Epigenomics; Female; Genetic Predisposition to Disease; Humans; Male; Methamphetamine; Promoter Regions, Genetic; Proto-Oncogene Proteins c-akt; Psychotic Disorders; Receptors, Dopamine D3; Receptors, Dopamine D4; Saliva; Transcriptome	2016
Distinct intrinsic functional brain network abnormalities in methamphetamine-dependent patients with and without a history of psychosis. Addiction biology, 2018, Volume: 23, Issue:1 Topics: Adult; Amphetamine-Related Disorders; Antipsychotic Agents; Attention; Brain; Case-Control Studies; Female; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Neural Pathways; Psychotic Disorders; Young Adult	2018
First-Rank Symptoms in Methamphetamine Psychosis and Schizophrenia. Psychopathology, 2016, Volume: 49, Issue:6 Topics: Adult; Delusions; Female; Hallucinations; Humans; Logistic Models; Male; Methamphetamine; Middle Aged; Psychoses, Substance-Induced; Psychotic Disorders; Schizophrenia	2016
Twelve-month course and outcome of methamphetamine-induced psychosis compared with first episode primary psychotic disorders. Early intervention in psychiatry, 2018, Volume: 12, Issue:5 Topics: Adult; Case-Control Studies; Female; Humans; Male; Methamphetamine; Prognosis; Prospective Studies; Psychoses, Substance-Induced; Psychotic Disorders; Young Adult	2018
Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders. Psychiatry research, 2017, Volume: 251 Topics: Adult; Amphetamine-Related Disorders; Brief Psychiatric Rating Scale; Delusions; Diagnosis, Differential; Diagnostic and Statistical Manual of Mental Disorders; Female; Hallucinations; Humans; Male; Methamphetamine; Psychoses, Substance-Induced; Psychotic Disorders; Substance Abuse, Intravenous	2017
Association study between the PIK4CA gene and methamphetamine use disorder in a Japanese population. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2009, Mar-05, Volume: 150B, Issue:2 Topics: Adult; Aged; Alleles; Amphetamine-Related Disorders; Asian People; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Male; Methamphetamine; Middle Aged; Minor Histocompatibility Antigens; Phosphotransferases (Alcohol Group Acceptor); Psychotic Disorders	2009
G72 gene is associated with susceptibility to methamphetamine psychosis. Progress in neuro-psychopharmacology & biological psychiatry, 2009, Aug-31, Volume: 33, Issue:6 Topics: Adult; Carrier Proteins; Case-Control Studies; Female; Genetic Predisposition to Disease; Humans; Intracellular Signaling Peptides and Proteins; Male; Methamphetamine; Middle Aged; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Psychotic Disorders	2009
The risk of psychotic symptoms associated with recreational methamphetamine use. Drug and alcohol review, 2010, Volume: 29, Issue:4 Topics: Adolescent; Adult; Amphetamine-Related Disorders; Cross-Sectional Studies; Female; Humans; Illicit Drugs; Male; Methamphetamine; Psychotic Disorders; Risk Factors; Young Adult	2010
Long-term outcomes in methamphetamine psychosis patients after first hospitalisation. Drug and alcohol review, 2010, Volume: 29, Issue:4 Topics: Adolescent; Adult; Amphetamine-Related Disorders; Databases, Factual; Female; Follow-Up Studies; Hospitalization; Humans; Male; Methamphetamine; Middle Aged; Psychotic Disorders; Thailand; Time Factors; Treatment Outcome; Young Adult	2010
Withdrawal symptoms in abstinent methamphetamine-dependent subjects. Addiction (Abingdon, England), 2010, Volume: 105, Issue:10 Topics: Adult; Amphetamine-Related Disorders; Case-Control Studies; Central Nervous System Stimulants; Depressive Disorder; Female; Humans; Male; Methamphetamine; Psychiatric Status Rating Scales; Psychotic Disorders; Recurrence; Substance Abuse Detection; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors	2010
Reduced amygdala and hippocampal volumes in patients with methamphetamine psychosis. Schizophrenia research, 2011, Volume: 132, Issue:2-3 Topics: Adult; Amygdala; Analysis of Variance; Brain Mapping; Case-Control Studies; Central Nervous System Stimulants; Female; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Middle Aged; Psychotic Disorders; Young Adult	2011
Lack of association between the Val158Met catechol-O-methyltransferase gene polymorphism and methamphetamine dependence. Neuro endocrinology letters, 2011, Volume: 32, Issue:4 Topics: Adolescent; Adult; Amphetamine-Related Disorders; Catechol O-Methyltransferase; Central Nervous System Stimulants; Czech Republic; Family Health; Female; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Male; Methamphetamine; Point Mutation; Polymorphism, Genetic; Psychotic Disorders; Young Adult	2011
Cannabinoid receptors mediate methamphetamine induction of high frequency gamma oscillations in the nucleus accumbens. Neuropharmacology, 2012, Volume: 63, Issue:4 Topics: Animals; Brain Waves; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Interneurons; Male; Methamphetamine; Nerve Tissue Proteins; Neurotoxicity Syndromes; Nucleus Accumbens; Piperidines; Psychomotor Performance; Psychotic Disorders; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Cannabinoid; Rimonabant	2012
Role of convergent activation of glutamatergic and dopaminergic systems in the nucleus accumbens in the development of methamphetamine psychosis and dependence. The international journal of neuropsychopharmacology, 2013, Volume: 16, Issue:6 Topics: Acoustic Stimulation; Analysis of Variance; Animals; Conditioning, Operant; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Dopamine; Dopamine Agents; Gene Expression Regulation; Glutamic Acid; Inhibition, Psychological; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Mutation; Nucleus Accumbens; Psychotic Disorders; Receptors, N-Methyl-D-Aspartate; Reflex, Startle; Tyrosine 3-Monooxygenase	2013
Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study. JAMA psychiatry, 2013, Volume: 70, Issue:3 Topics: Adult; Alcohol Drinking; Amphetamine-Related Disorders; Australia; Central Nervous System Stimulants; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Longitudinal Studies; Male; Marijuana Smoking; Methamphetamine; Odds Ratio; Prospective Studies; Psychoses, Substance-Induced; Psychotic Disorders; Risk Factors	2013
Metabolite alterations in basal ganglia associated with methamphetamine-related psychiatric symptoms. A proton MRS study. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2002, Volume: 27, Issue:3 Topics: Adult; Analysis of Variance; Aspartic Acid; Basal Ganglia; Central Nervous System Stimulants; Choline; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Methamphetamine; Phosphocreatine; Psychiatric Status Rating Scales; Psychotic Disorders	2002
Acute psychotic reaction after inhaling methylamphetamine. British medical journal, 1954, Jun-26, Volume: 1, Issue:4877 Topics: Amphetamine; Amphetamines; Humans; Mental Disorders; Methamphetamine; Psychoses, Substance-Induced; Psychotic Disorders	1954
[Contribution to a biochemical concept of experimental psychoses. VIII. Effect of iproniazid (marsilid), desoxyephedrine (pervitin) & lysergic acid diethylamide on blood & cerebral metabolism in the conscious rabbit]. Comptes rendus des seances de la Societe de biologie et de ses filiales, 1958, Volume: 152, Issue:11 Topics: Amphetamine; Amphetamines; Animals; Biochemical Phenomena; Brain; Consciousness; Iproniazid; Lysergic Acid Diethylamide; Methamphetamine; Niacin; Nicotinic Acids; Psychotic Disorders; Rabbits	1958
[Study of a biochemical concept of experimental psychoses. IX. Effect of prolonged administration of desoxyephedrine (pervitine) and iproniazid (marsilid) on body fluid balance and cerebral metabolism of the waking rabbit]. Comptes rendus des seances de la Societe de biologie et de ses filiales, 1958, Volume: 152, Issue:12 Topics: Amphetamine; Amphetamines; Animals; Body Fluids; Brain; Iproniazid; Methamphetamine; Niacin; Nicotinic Acids; Pharmaceutical Preparations; Psychotic Disorders; Rabbits; Water-Electrolyte Balance	1958
[The "stimulation threshold" for methylamphetamine by means of fractionated Weckanalysis]. Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali, 1962, Dec-31, Volume: 86 Topics: Bipolar Disorder; Mental Disorders; Methamphetamine; Neurotic Disorders; Psychotic Disorders; Schizophrenia	1962
[Preliminary contribution to the study of fractionated Weckanalysis with methylphenidylate]. Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali, 1962, Dec-31, Volume: 86 Topics: Bipolar Disorder; Humans; Mental Disorders; Methamphetamine; Neurotic Disorders; Psychotic Disorders; Schizophrenia	1962
[CLINICAL ASPECTS OF MODEL PSYCHOSES]. Nordisk psykiatrisk tidsskrift. Nordic journal of psychiatry, 1964, Volume: 18 Topics: Anorexia Nervosa; Convulsive Therapy; Hospitals, Psychiatric; Humans; Insulin; Lysergic Acid Diethylamide; Mental Disorders; Methamphetamine; Methylphenidate; Neurotic Disorders; Obsessive-Compulsive Disorder; Paraphilic Disorders; Pharmacology; Psychotic Disorders; Schizophrenia	1964
REACTIONS TO USE OF AMPHETAMINES AS OBSERVED IN A PSYCHIATRIC HOSPITAL. New York state journal of medicine, 1964, May-15, Volume: 64 Topics: Alcoholism; Amobarbital; Amphetamine; Amphetamines; Barbiturates; Dextroamphetamine; Hospitals, Psychiatric; Humans; Methamphetamine; Narcotics; Paranoid Disorders; Phenmetrazine; Psychoses, Substance-Induced; Psychotic Disorders; Schizophrenia; Substance Withdrawal Syndrome; Substance-Related Disorders; Toxicology	1964
EVOKED POTENTIAL STUDIES IN PSYCHIATRIC PATIENTS. Annals of the New York Academy of Sciences, 1964, May-08, Volume: 112 Topics: Amobarbital; Antisocial Personality Disorder; Biomedical Research; Bipolar Disorder; Electric Stimulation; Electroconvulsive Therapy; Electroencephalography; Evoked Potentials; Humans; Hypnosis; Imipramine; Lysergic Acid Diethylamide; Mental Disorders; Methamphetamine; Psychophysiology; Psychotic Disorders; Reflex; Schizophrenia; Ulnar Nerve; Vision, Ocular	1964
Enhancement of central dopaminergic activity in the kainate model of temporal lobe epilepsy: implication for the mechanism of epileptic psychosis. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2004, Volume: 29, Issue:7 Topics: Analysis of Variance; Animals; Behavior, Animal; Brain Chemistry; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Electrochemistry; Epilepsy, Temporal Lobe; Haloperidol; In Vitro Techniques; Kainic Acid; Male; Methamphetamine; Microdialysis; Motor Activity; Psychotic Disorders; Rats; Rats, Sprague-Dawley	2004
Association analysis of dopamine D2-like receptor genes and methamphetamine abuse. Psychiatric genetics, 2004, Volume: 14, Issue:4 Topics: Female; Gene Frequency; Genotype; Humans; Male; Methamphetamine; Psychotic Disorders; Receptors, Dopamine D2; Substance-Related Disorders	2004
Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2005, Jul-05, Volume: 136B, Issue:1 Topics: Adult; Amphetamine-Related Disorders; Comorbidity; Family; Female; Humans; Interviews as Topic; Male; Mental Disorders; Methamphetamine; Prevalence; Psychotic Disorders; Risk Factors; Schizophrenia	2005
An association study between catechol-O-methyl transferase gene polymorphism and methamphetamine psychotic disorder. Psychiatric genetics, 2006, Volume: 16, Issue:4 Topics: Adult; Aged; Catechol O-Methyltransferase; Female; Gene Frequency; Genotype; Humans; Male; Methamphetamine; Middle Aged; Polymorphism, Genetic; Psychotic Disorders; Recurrence; Reference Values	2006
Alteration in the GABAergic network of the prefrontal cortex in a potential animal model of psychosis. Journal of neural transmission (Vienna, Austria : 1996), 2007, Volume: 114, Issue:5 Topics: Aging; Animals; Cell Differentiation; Disease Models, Animal; Dopamine Uptake Inhibitors; Environment Design; gamma-Aminobutyric Acid; Gerbillinae; Interneurons; Male; Methamphetamine; Nerve Net; Prefrontal Cortex; Presynaptic Terminals; Psychotic Disorders; Pyramidal Cells; Sensory Deprivation; Synapses; Synaptic Transmission	2007
Clinical course and outcomes of methamphetamine-dependent adults with psychosis. Journal of substance abuse treatment, 2008, Volume: 35, Issue:4 Topics: Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Diagnosis, Dual (Psychiatry); Female; Follow-Up Studies; Humans; Male; Mental Health Services; Methamphetamine; Psychotic Disorders; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome	2008
A neuroendocrine study of adrenoceptor function in endogenous depression. Acta psychiatrica Scandinavica. Supplementum, 1980, Volume: 280 Topics: Adjustment Disorders; Depression; Growth Hormone; Humans; Hydrocortisone; Methamphetamine; Psychotic Disorders; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Serotonin	1980
Methamphetamine abuse presenting as dysuria following urethral insertion of tablets. Annals of emergency medicine, 1984, Volume: 13, Issue:3 Topics: Adult; Hematuria; Humans; Male; Methamphetamine; Psychotic Disorders; Pyuria; Substance-Related Disorders; Urethra; Urination Disorders	1984
Factors for susceptibility to episode recurrence in spontaneous recurrence of methamphetamine psychosis. Annals of the New York Academy of Sciences, 2002, Volume: 965 Topics: Dopamine; Female; Genetic Predisposition to Disease; Humans; Methamphetamine; Norepinephrine; Prisoners; Psychotic Disorders; Recurrence; Reference Values; Stress, Psychological; Substance-Related Disorders; Tyrosine	2002
Effects of disulfiram on the amphetamine-induced behavioral syndrome in the cat as a model of psychosis. National Institute on Drug Abuse research monograph series, 1975, Issue:3 Topics: Animals; Behavior, Animal; Cats; Disease Models, Animal; Disulfiram; Drug Interactions; Female; Humans; Methamphetamine; Motor Activity; Psychotic Disorders; Stereotyped Behavior; Time Factors	1975
Response of depressed patients to methylamphetamine. The British journal of psychiatry : the journal of mental science, 1974, Volume: 125 Topics: Adjustment Disorders; Adult; Alcoholism; Bipolar Disorder; Female; Histrionic Personality Disorder; Humans; Injections, Intravenous; Male; Methamphetamine; Middle Aged; Neurotic Disorders; Personality Disorders; Psychological Tests; Psychotic Disorders; Schizophrenia; Self-Assessment; Sex Factors; Substance-Related Disorders	1974
[Subclinical sleep activity in the EEG]. Psychiatria clinica, 1969, Volume: 2, Issue:6 Topics: Adult; Amphetamine; Arousal; Brain Diseases; Cataplexy; Child; Child Behavior Disorders; Electroencephalography; Enuresis; Epilepsy; Erectile Dysfunction; Female; Humans; Hyperventilation; Injections, Intravenous; Injections, Subcutaneous; Male; Methamphetamine; Neurotic Disorders; Psychotic Disorders; Sleep; Theophylline; Wakefulness	1969
Experimental geriatrics. Selection and prediction of therapeutic responsiveness in geriatric patients. Canadian Psychiatric Association journal, 1968, Volume: 13, Issue:6 Topics: Aged; Amobarbital; Analysis of Variance; Carbon Dioxide; Hospitalization; Humans; Methamphetamine; Neurocognitive Disorders; Paranoid Disorders; Psychiatric Status Rating Scales; Psychological Tests; Psychotic Disorders; Schizophrenia	1968